Gynecology

FRIDAY, NOVEMBER 20

09:00-10:30 CONTRACEPTION – THE UNDER-APPRECIATED BENEFITS
Hall II
Capsule
Chairpersons Christian Egarter, Austria
Johannes Bitzer, Switzerland 
 09:00-09:25 Irritable bowel syndrome
Vincenzo Stanghellini, Italy
 09:25-09:50 Asthma and rheumatoid arthritis
Alessandra Graziottin, Italy
 09:50-10:15 Optimizing psychosexual health with perimenopausal contraception
Johannes Bitzer, Switzerland 
10:15-10:30 Discussion
10:30-11:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING

 

EXHIBITION AND E-POSTER HALL
11:00-12:30 ADVANCES IN HORMONAL AND NON-HORMONAL RESEARCH
Hall II
Capsule  
Chairperson Mark Brincat, Malta
11:00-11:40 Debate: Should androgens be routinely offered to optimize quality of life in menopause?
For: Alessandra Graziottin, Italy
Against: Johannes Bitzer, Switzerland
Discussion
11:40-12:05 How to overcome hormone resistance?
Ludwig Kiesel, Germany
12:05-12:30 New SERMS / TSECS: Can they be an HRT substitute?
Santiago Palacios, Spain
12:30-15:05 VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS VARIOUS HALLS
12:30-14:00 NON-ABLATIVE AND MICRO-ABLATIVE LASERS IN GYNECOLOGY Hall II
Capsule LASER in medicine stands for a number of diverse devices. They radiate different energy at different wavelengths and produce different effects in different tissues. Er:YAG and CO2 lasers have been introduced, through last decade, for gynecology applications. Growing evidence supports non-ablative, and micro-ablative laser technology as an effective intervention for stress urinary icontinence, vulvo-vaginal atrophy, lichen sclerosus atrophycus, vaginal relaxation, etc. Despite of warnings from leading international organizations against the use of energy-based devices (EBDs) in certian fields of gynelology, contemporary evidence, that is going to be presented in this symposium, confirm safety and efficacy of laser treatment for genitourinary syndrome of menopause (GSM).
Chairperson Ivan Fistonić, Croatia
 12:30-12:50 Laser based vaginal treatments: Physical principles and biological effect
Menachem Alcalay, Israel
 12:50-13:10 CO2 laser applications in gynecology
Stefano Salvatore, Italy
 13:10-13:30 Potential of laser therapy in vulvar pathologies
Mark Brincat, Malta
13:30-13:50  Er: YAG vaginal laser therapy – hype or established treatment?
Ivan Fistonić, Croatia
13:50-14:00 Discussion
14:00-14:05 BREAK
 
14:05-15:05 INDUSTRY SUPPORTED SESSION
Hall II
15:05-15:10 BREAK
 
15:10-16:40 VULVAR PAIN AND CO-MORBITIES Hall II
Chairpersons Ludwig Kiesel, Germany
Alessandra Graziottin
,, Italy
15:10-15:35 Vulvar pains and co-morbidities: Data from 1183 cases
Alessandra Graziottin, Italy 
15:35-16:00 Vagina as an androgen target
Linda Vignozzi, Italy 
16:00-16:40 Debate: Is laser treatment first line choice for Genitourinary Syndrome of Menopause (GSM)?
Yes: Zdenko Vizintin, Slovenia
No: Tim Hillard, UK
Discussion
16:40-17:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING

 

EXHIBITION AND E-POSTER HALL
17:00-18:30 HPV Hall II
Chairperson  Xavier Bosch, Spain
17:00-17:20 Natural history of HPV among females: Implications for control
Anna Barbara Moscicki, USA
17:20-17:40 

Lessons learned from CC screening in KP: intervals, primary HPV testing, how to limit the harms of screening, management by individual risk and impact of HPV vaccines
Walter Kinney, USA

17:40-18:00

What is new in preventive and therapeutic vaccines
John T. Schiller, USA

18:00-18:20 

Real world effectiveness and duration of protection of HPV vaccination
Suzanne Garland, Australia

18:20-18:30
Q&A

SATURDAY, NOVEMBER 21

09:00-10:30 OVARIAN CANCER – NEW INSIGHTS AND CURRENT TREATMENT STANDARDS Hall II
Chairpersons Jalid SehouliGermany
Elena Braicu, Germany
09:00-09:20 Molecular understanding of ovarian cancer
Elena Braicu, Germany
09:20-09:45 Current role of primary surgery
Robert Armbrust, Germany
09:45-10:05 Maintenance therapy in advanced ovarian cancer
Klaus Pietzner, Germany
10:05-10:30 Relapsed ovarian cancer
Jalid Sehouli, Germany
10:30-11:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING

 

EXHIBITION AND E-POSTER HALL
11:00-12:30 RECENT ADVANCES ON POI AND LINK WITH DNA REPAIR/CANCER GENES
Hall II
Capsule  
Chairperson Lisa Webber, UK
11:00-11:25 BRCA2 and Fancm mutants in primary ovarian insufficiency without cancer or Fanconi anemia trait
Micheline Misrahi, France
11:25-11:55 Debate: Understanding the genetics of POI is important in clinical practice for the management of affected women and their families
Pro: Micheline Misrahi, France
Against: Rene Frydman, France
Discussion
11:55-12:15 Is there a need for a POI network/database?
Nick Panay, UK
12:15-12:30 POI and National Genomics: The experience in England
Brianna Cloke, UK
12:30-15:05 VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS VARIOUS HALLS
12:30-14:00 PCOS AT MENOPAUSE 
Hall II
Capsule
Chairperson Santiago Palacios, Spain
12:30-13:00 Is there an increased CVD risk in PCOS women?
Bart Fauser, Netherlands
13:00-13:30 Delayed fertility and later menopause in PCOS
Joop Laven, Netherlands
13:30-14:00 Should ovarian tissue reimplantation be considered for all women to postpone menopause?
Mark Brincat, Malta
14:00-14:05 BREAK
 
14:05-15:05 ISMAAR SESSION: MILD IVF Hall II
Chairpersons TBA
14:05-14:45 Debate: Should mild IVF be the new norm in the post-COVID era? 
For: Geeta Nargund, UK
Against: Georg Griesinger, Germany
Discussion
14:45-15:05 Ovarian placental shift
Georg Griesinger, Germany
15:05-15:10 BREAK
 
15:10-16:40 ENDOMETRIOSIS 
Hall II
Capsule
Chairperson Jessica Ybanez-Morano, USA
Olivier Donnez, Belgium
15:10-15:35 Long term risk of cancer in women carrying unoperated ovarian endometriomas: Immediate surgery, delayed surgery or never surgery?
Paolo Vercellini, Italy
15:35-15:55 State-of-the-art of medical therapy or how to explain pain in endometriosis
Sylvia Mechsner, Germany
15:55-16:20 Special countercurrent lecture: The role of miRNA as a marker for endometriosis
Ludwig Kiesel, Germany
16:20-16:40 Vaginal Microbiome: A new frontier into antibiotic resistant superbugs
Gary Ventolini, USA
16:40-17:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING

 

EXHIBITION AND E-POSTER HALL
17:00-18:30 SLS: THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS Hall II
Chairperson Jessica Ybanez-Morano, USA
17:00-17:20 The future in fertility surgery
Mona Orady, USA
17:20-17:40 Dealing with parametrium endometriosis
Thiers Soares Raymundo, USA
17:40-18:05 Updates on reduced site laparoscopy
Jessica Ybanez-Morano, USA
18:05-18:30 Stop resecting septum
Fulco van der Veen, Netherlands